On Jul.20, 2009, in the first session of evaluation on China top 20 public pharma companies with most competitiveness, China Pharma-a Hongkong public company of CSPC group was selected by its superb strength.
On the award ceremony, Mr.Hu Bin secretary with Board of Director of CSPC group stressed that CSPC has became as industry benchmark and made its own contribution for our pharma field and health of the public through its own wisdom and effort.
This evaluation is co-organized 《Pharma Manager》magazine of China Pharma firms management association, China Pharma eonomic research center of Peking University and Beijing Junhe Consultation Co.,ltd, which was initiated from Feb.2009, and analyzed financial status of 132 public firms listed in Shanghai, Hongkong, Newyork, NASDK with annul sales over 100million Yuan, the evaluators include experts, stock analyzers and financial reporters, whose opinipons took up 30% of total score, where the rest 70% counted by the profit growth in past three years, net revenue on equity, absolute sales and profit value in 2008,
2009-7-20 |